JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


First published online July 16, 2008, 10.2967/jnumed.107.050021
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in JNM
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by von Forstner, C.
Right arrow Articles by Brenner, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by von Forstner, C.
Right arrow Articles by Brenner, W.

Gene Expression Patterns and Tumor Uptake of 18F-FDG, 18F-FLT, and 18F-FEC in PET/MRI of an Orthotopic Mouse Xenotransplantation Model of Pancreatic Cancer

Corinna von Forstner*,1, Jan-Hendrik Egberts*,2, Ole Ammerpohl2, Dagmara Niedzielska3, Ralph Buchert3, Pal Mikecz3, Udo Schumacher4, Kersten Peldschus5, Gerhard Adam5, Christian Pilarsky6, Robert Grutzmann6, Holger Kalthoff2, Eberhard Henze1 and Winfried Brenner3

1 Department of Nuclear Medicine, University Hospital of Schleswig-Holstein, Campus Kiel, Kiel, Germany; 2 Department of General Surgery and Thoracic Surgery, University Hospital of Schleswig-Holstein, Campus Kiel, Kiel, Germany; 3 Department of Nuclear Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; 4 Department of Anatomy II Experimental Morphology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; 5 Department of Diagnostic and Interventional Radiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; and 6 Department of Visceral, Thoracic, and Vascular Surgery, University Hospital Carl Gustav Carus, Technical University of Dresden, Dresden, Germany


Figure 1
View larger version (21K):
[in this window]
[in a new window]

 
FIGURE 1.  Tumor uptake of 18F-FDG (A), 18F-FLT (B), and 18F-FEC (C) in mouse 1 with a BxPc3 tumor (row 1: MRI; row 2: PET; row 3: PET/MRI). Tumor is readily visible in abdomen on MR images (arrows). (A) There is no increased 18F-FDG uptake within tumor; hot spots are 18F-FDG activity within kidneys. (B) Tumor is readily visible, showing intense 18F-FLT uptake that is higher than in any other organ. (C) There is no 18F-FEC uptake within tumor; liver and kidneys show pronounced tracer uptake.

 

Figure 2
View larger version (18K):
[in this window]
[in a new window]

 
FIGURE 2.  Expression of genes involved in membrane transport or metabolism of 18F-FDG in pancreatic cancer cell lines PancTuI, Colo357, and BxPc3, compared with expression in normal pancreatic duct cells (n = 13) and PDAC cells (n = 19) as determined by microarray analysis. Mean expression level is marked by a line.

 

Figure 3
View larger version (14K):
[in this window]
[in a new window]

 
FIGURE 3.  Expression of genes involved in membrane transport or metabolism of 18F-FLT in pancreatic cancer cell lines PancTuI, Colo357, and BxPc3, compared with expression in normal pancreatic duct cells (n = 13) and PDAC cells (n = 19) as determined by microarray analysis. Mean expression level is marked by a line.

 

Figure 4
View larger version (21K):
[in this window]
[in a new window]

 
FIGURE 4.  Expression of genes involved in membrane transport or metabolism of 18F-FEC in pancreatic cancer cell lines PancTuI, Colo357, and BxPc3, compared with expression in normal pancreatic duct cells (n = 13) and PDAC cells (n = 19) as determined by microarray analysis. Mean expression level is marked by a line.

 





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2008 by the Society of Nuclear Medicine.